Sulfuric Acid

Sulfuric Acid

SCHEMBL582397

CCCC[n+]1ccn(C)c1.O=S(=O)([O-])O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HSP90AA1 P07900 1/20 0.36
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
PABPC1 P11940 1/20 0.36
HPGD P15428 1/20 0.36
RXFP1 Q9HBX9 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
BLM P54132 1/20 0.35
FDPS P14324 3/20 0.35
APAF1 O14727 2/20 0.34
LMNA P02545 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28084954 0.97 KDM4E (0.35) SMN1; SMN2KMT2AMEN1HSP90AA1KDM4E
Sulfuric Acid SCHEMBL28861350 0.95 KDM4E (0.34) SMN1; SMN2KMT2AMEN1HSP90AA1KDM4E
Sulfuric Acid SCHEMBL28653445 0.95 MEN1 (0.38) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL27994261 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL1293066 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL1293539 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL18112165 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL28019076 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL1293400 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1
Sulfuric Acid SCHEMBL3687205 0.94 MEN1 (0.40) SMN1; SMN2KMT2AMEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022105-A1 Method for Preparing 2,5-Furandicarboxylic Acid NATIONAL SUN YAT SEN UNIVERSITY (TW) 2026-01-22 US claimed
US-20250347033-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LTD (GB) 2025-11-13 US claimed
EP-4617650-A1 FLEXIBLE ELECTROLYTE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Zhengzhou Winsen Electronics Technology Co., Ltd (CN) 2025-09-17 EP claimed
US-20250283255-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-09-11 US claimed
CN-116730815-B Method for circularly synthesizing aldehyde compound 中国石油大学(华东) 2025-05-27 CN claimed
CN-119874060-A Scale and corrosion inhibitor for water and preparation method thereof 珠海津环环保工程有限公司 2025-04-25 CN claimed
WO-2025012681-A1 SYSTEM AND METHOD FOR CONCENTRATING LITHIUM BRINES AND PURIFYING WATER UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN (CL) 2025-01-16 WO claimed
CN-118580418-A Electrochromic polymer, preparation method thereof, electrochromic device and electronic equipment 华为技术有限公司 2024-09-03 CN claimed
EP-3986978-B1 AQUEOUS DELAYED ACID SYSTEM FOR WELL STIMULATION BAKER HUGHES HOLDINGS LLC (US) 2024-05-15 EP claimed
US-11939521-B2 Reuse of hypersaline brine with ionic liquids SAUDI ARABIAN OIL COMPANY (SA) 2024-03-26 US claimed
WO-2012087442-A1 POLYBENZIMIDAZOLE SOLUTION IN AN IONIC LIQUID PBI PERFORMANCE PRODUCTS, INC. (US) 2012-06-28 WO claimed
US-20120142830-A1 POLYBENZIMIDAZOLE SOLUTION IN AN IONIC LIQUID DAWKINS BOBBY G (US) 2012-06-07 US claimed
US-20110314967-A1 IMPROVING THE RECOVERY OF PRECIOUS METALS FROM RECALCITRANT REFRACTORY ORE FRAMROZE BOMI P (IN) 2011-12-29 US claimed
US-20110155635-A1 PROCESS FOR REMOVING METALS FROM RESID UOP LLC (US) 2011-06-30 US claimed
US-20110155644-A1 PROCESS FOR REMOVING METALS FROM VACUUM GAS OIL UOP LLC (US) 2011-06-30 US claimed
US-20110155645-A1 PROCESS FOR REMOVING METALS FROM CRUDE OIL UOP LLC (US) 2011-06-30 US claimed
US-20110152413-A1 POLYBENZIMIDAZOLE SOLUTION IN AN IONIC LIQUID PBI PERFORMANCE PRODUCTS, INC. 2011-06-23 US claimed
US-20100331599-A1 ALKYLATION CATALYZED BY BINARY MIXTURES OF ACID AND IONIC LIQUID SUBRAMANIAM BALA 2010-12-30 US claimed
US-7528186-B2 Tire; no need for an electrically conductive strip through or around the tread; 1-ethyl-3-methylimidazonium ethyl sulfate, 1-butyl-3-methylimidazolium chloride, 1-butyl-3-methylimidazonium acetate, 1-butyl-3-methylimidazonium hydrogen sulfate, or 1-butyl-3-methylimidazonium tetrachloro aluminate THE GOODYEAR TIRE & RUBBER COMPANY (US) 2009-05-05 US claimed
US-20070293610-A1 Tire; no need for an electrically conductive strip through or around the tread; 1-ethyl-3-methylimidazonium ethyl sulfate, 1-butyl-3-methylimidazolium chloride, 1-butyl-3-methylimidazonium acetate, 1-butyl-3-methylimidazonium hydrogen sulfate, or 1-butyl-3-methylimidazonium tetrachloro aluminate GOODYEAR TIRE & RUBBER COMPANY, THE 2007-12-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022105-A1 Method for Preparing 2,5-Furandicarboxylic Acid POF1B, SOD1, CYP2F1 SMN1; SMN2 714/4885KMT2A 3403/4885MEN1 1726/4885
US-20100331599-A1 ALKYLATION CATALYZED BY BINARY MIXTURES OF ACID AND IONIC LIQUID BPTF, BPGM, MPST SMN1; SMN2 1611/4885KMT2A 1823/4885MEN1 2602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.